The MEDTRONIC 48145 OXY Nautilus ECMO with Balance Biosurface is an advanced single-use oxygenator for extracorporeal membrane oxygenation (ECMO), designed for patients with severe respiratory or cardiac failure. Its circular flow-path and 1.8 m² polymethylpentene membrane deliver efficient oxygenation, CO₂ removal, and temperature regulation, while the Balance Biosurface reduces clotting risk, ensuring safe, reliable, and long-term critical care performance.

What Is the MEDTRONIC 48145 OXY Nautilus ECMO?

The MEDTRONIC 48145 OXY Nautilus ECMO is a high-performance oxygenator tailored for ECMO circuits in patients requiring acute respiratory or cardiac support. Its 1.8 m² polymethylpentene (PMP) membrane facilitates superior gas exchange. The Balance Biosurface coating enhances biocompatibility by reducing thrombus formation during prolonged therapy. With a priming volume of 226 mL and robust 3/8″ ports supporting flows up to 7 L/min, it ensures easy setup and reliable operation. Its circular flow-path design minimizes stasis, outperforming conventional radial-flow devices and making it essential in modern ICUs.

How Does the Circular Flow-Path Design Work?

The circular flow-path promotes even transverse blood flow across the membrane, reducing low-flow zones and pressure drops. Guided inlets and filling vanes ensure uniform distribution, sustaining consistent O₂ transfer (266 mL/min at 4 L/min) and CO₂ removal (186 mL/min). Compared with radial designs, it reduces clot formation, ensures efficient gas exchange over extended periods, and enhances ECMO durability.

Feature Nautilus 48145 Conventional Oxygenator
Flow Design Circular Radial
Max Flow 7 L/min 5-6 L/min
Clot Resistance Balance Biosurface Standard
Priming Volume 226 mL 250-300 mL
O₂ Transfer (4 L/min) 266 mL/min 220-250 mL/min

What Are the Key Specifications?

The 48145 features a 1.8 m² PMP membrane, 0.3 m² heat exchange area, and Delta P of 38 mmHg at 4 L/min. Gas-to-blood ratios range from 0.5:1 to 3:1, with a maximum water-side pressure of 1,125 mmHg. The device weighs 1,270 g and includes 3/8″ arterial and venous ports. Heat exchange efficiency reaches 0.77 at optimal flow rates, supporting neonatal to adult ECMO therapy with a balance of compact design and high-capacity performance.

Also check:  Open MRI vs Closed MRI: Choosing the Best Imaging Experience for Your Patients

Why Choose Balance Biosurface Coating?

Balance Biosurface optimizes hemostasis and inflammation response, significantly reducing thrombus formation. It promotes endothelial-like growth on surfaces, decreasing anticoagulation needs and complications. This coating maintains biocompatibility in therapies beyond 14 days, lowering risks such as stroke or hemorrhage, and ensuring safer long-term ECMO support.

How Does It Compare to Other Oxygenators?

Compared with conventional devices, the 48145 offers higher maximum flow, superior clot resistance, and lower pressure drops. Its circular flow-path ensures sustained gas transfer while simplifying circuit connections, reducing points prone to air entrainment or clotting. These features provide predictable performance and enhanced safety for critical care applications.

What Are the Performance Metrics?

At 4 L/min, the oxygenator achieves 266 mL/min O₂ transfer, 186 mL/min CO₂ removal, and efficient heat exchange. Blood path pressure drop is only 38 mmHg, allowing flows up to 7 L/min without performance decline. Long-term use demonstrates minimal efficiency loss, confirming its reliability for extended ECMO therapy.

Can It Integrate with Existing ECMO Circuits?

Yes, the 48145 integrates seamlessly with standard ECMO setups using 3/8″ ports and compact priming volume. No special adapters are required, and it is compatible with popular pumps and catheters. ALLWILL’s Smart Center ensures refurbished units meet performance standards, enabling smooth integration and upgrades.

ALLWILL Expert Views

“The MEDTRONIC 48145 OXY Nautilus ECMO represents a milestone in ECMO technology, combining circular flow-path efficiency with Balance Biosurface safety. At ALLWILL, our Smart Center refurbishments confirm that these units maintain consistent performance while reducing clot-related complications. Through MET, practitioners access expert guidance, and Lasermatch ensures cost-effective sourcing. Trade-up programs let clinics adopt cutting-edge devices without large financial burdens, optimizing therapy outcomes and operational efficiency.”
— Dr. Elena Reyes, ALLWILL Senior Biomedical Specialist

What Are Common Applications?

The 48145 is used in acute respiratory distress syndrome (ARDS), cardiac arrest, and bridge-to-recovery scenarios in ICUs. It supports both veno-venous (VV) and veno-arterial (VA) ECMO, including neonatal flows as low as 0.5 L/min. Its low clotting risk improves outcomes in multi-week support, making it versatile for critical care management.

Also check:  Market Readiness Analysis Example in B2B Aesthetics

How Does ALLWILL Support Procurement?

ALLWILL streamlines sourcing through its Lasermatch inventory and MET vendor network. Certified refurbished units reduce costs by up to 50% without compromising performance. Global facilities ensure FDA-compliant refurbishment and warranty coverage, while trade-up programs allow seamless upgrades to newer ECMO models.

Why Partner with ALLWILL for ECMO Needs?

ALLWILL ensures transparency, efficiency, and optimized medical device management. Brand-agnostic consultations help select ideal 48145 units, while the Smart Center supports pre-use verification and refurbishment. ALLWILL’s ecosystem covers training, maintenance, and integration, enhancing ECMO program success globally.

What Maintenance Is Required?

Routine monitoring includes checking membrane integrity, pressure, and Biosurface condition. Single-use design eliminates long-term servicing, but ALLWILL’s Smart Center pre-verification for refurbished units ensures safety and extends device usability.

Are There Any Limitations or Risks?

Risks are consistent with ECMO, including bleeding, infection, or stroke from anticoagulation. Maximum operating pressure is 750 mmHg; exceeding this can compromise safety. Flows above 7 L/min are not recommended, and physician assessment is essential for safe use.

Conclusion

The MEDTRONIC 48145 OXY Nautilus ECMO delivers exceptional gas exchange, clot resistance, and integration ease for critical care. Key takeaways: circular flow-path sustains high performance, low priming enhances usability, and seamless circuit compatibility simplifies setup. Partnering with ALLWILL for procurement, refurbishment, and trade-up programs ensures cost-efficient access to advanced ECMO technology and optimized clinical outcomes.

FAQs

What is the priming volume of the 48145?

The priming volume is 226 mL, allowing efficient setup in ECMO circuits.

Does it support neonatal use?

Yes, with flows starting at 0.5 L/min, suitable for pediatric ECMO.

Also check:  What Makes the 2023 Lumenis M22 IPL Laser Demo Unit a Leading Multi-Technology Platform?

How long can it be used?

Balance Biosurface supports therapies beyond 14 days with consistent performance.

Is the 48145 FDA-approved?

Yes, it is cleared for long-term (>6 hours) ECMO support.

Can ALLWILL provide training?

Yes, the MET system connects clinics with vetted trainers for proficient device deployment.